FOLH1 and prostate neoplasm: In another aptamer-based study, anti-prostate-specific membrane antigen (PSMA) aptamers were immobilized on a microchip and fabricated into a high-throughput micro-sampling unit by Dharmasiri et al. [111] to capture rare circulating prostate tumor cells.